Global mRNA Vaccine And Therapeutics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03250320

Publication Date:

March 13, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global mRNA Vaccine And Therapeutics market size was valued at US$ 35880 million in 2023. With growing demand in downstream market, the mRNA Vaccine And Therapeutics is forecast to a readjusted size of US$ 50770 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global mRNA Vaccine And Therapeutics market. mRNA Vaccine And Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Vaccine And Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Vaccine And Therapeutics market.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on mRNA Vaccine And Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Vaccine And Therapeutics market. It may include historical data, market segmentation by Type (e.g., Infectious Disease, Cancer), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Vaccine And Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Vaccine And Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Vaccine And Therapeutics industry. This include advancements in mRNA Vaccine And Therapeutics technology, mRNA Vaccine And Therapeutics new entrants, mRNA Vaccine And Therapeutics new investment, and other innovations that are shaping the future of mRNA Vaccine And Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Vaccine And Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Vaccine And Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Vaccine And Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Vaccine And Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Vaccine And Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Vaccine And Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Vaccine And Therapeutics market.
Market Segmentation:
mRNA Vaccine And Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Infectious Disease
Cancer
Others
Segmentation by application
Hospital
Research Institual
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Argos Therapeutics
BioNTech
CureVac
eTheRNA
Ethris
In-Cell-Art
Moderna Therapeutics
Sangamo Therapeutics
Tiba Biotechnology
Translate Bio

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Vaccine And Therapeutics Market Size 2019-2030
2.1.2 mRNA Vaccine And Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 mRNA Vaccine And Therapeutics Segment by Type
2.2.1 Infectious Disease
2.2.2 Cancer
2.2.3 Others
2.3 mRNA Vaccine And Therapeutics Market Size by Type
2.3.1 mRNA Vaccine And Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global mRNA Vaccine And Therapeutics Market Size Market Share by Type (2019-2024)
2.4 mRNA Vaccine And Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Research Institual
2.5 mRNA Vaccine And Therapeutics Market Size by Application
2.5.1 mRNA Vaccine And Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global mRNA Vaccine And Therapeutics Market Size Market Share by Application (2019-2024)
3 mRNA Vaccine And Therapeutics Market Size by Player
3.1 mRNA Vaccine And Therapeutics Market Size Market Share by Players
3.1.1 Global mRNA Vaccine And Therapeutics Revenue by Players (2019-2024)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Vaccine And Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Vaccine And Therapeutics by Regions
4.1 mRNA Vaccine And Therapeutics Market Size by Regions (2019-2024)
4.2 Americas mRNA Vaccine And Therapeutics Market Size Growth (2019-2024)
4.3 APAC mRNA Vaccine And Therapeutics Market Size Growth (2019-2024)
4.4 Europe mRNA Vaccine And Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa mRNA Vaccine And Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)
5.2 Americas mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)
5.3 Americas mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccine And Therapeutics Market Size by Region (2019-2024)
6.2 APAC mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)
6.3 APAC mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Vaccine And Therapeutics by Country (2019-2024)
7.2 Europe mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)
7.3 Europe mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Vaccine And Therapeutics by Region (2019-2024)
8.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global mRNA Vaccine And Therapeutics Market Forecast
10.1 Global mRNA Vaccine And Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global mRNA Vaccine And Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas mRNA Vaccine And Therapeutics Forecast
10.1.3 APAC mRNA Vaccine And Therapeutics Forecast
10.1.4 Europe mRNA Vaccine And Therapeutics Forecast
10.1.5 Middle East & Africa mRNA Vaccine And Therapeutics Forecast
10.2 Americas mRNA Vaccine And Therapeutics Forecast by Country (2025-2030)
10.2.1 United States mRNA Vaccine And Therapeutics Market Forecast
10.2.2 Canada mRNA Vaccine And Therapeutics Market Forecast
10.2.3 Mexico mRNA Vaccine And Therapeutics Market Forecast
10.2.4 Brazil mRNA Vaccine And Therapeutics Market Forecast
10.3 APAC mRNA Vaccine And Therapeutics Forecast by Region (2025-2030)
10.3.1 China mRNA Vaccine And Therapeutics Market Forecast
10.3.2 Japan mRNA Vaccine And Therapeutics Market Forecast
10.3.3 Korea mRNA Vaccine And Therapeutics Market Forecast
10.3.4 Southeast Asia mRNA Vaccine And Therapeutics Market Forecast
10.3.5 India mRNA Vaccine And Therapeutics Market Forecast
10.3.6 Australia mRNA Vaccine And Therapeutics Market Forecast
10.4 Europe mRNA Vaccine And Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany mRNA Vaccine And Therapeutics Market Forecast
10.4.2 France mRNA Vaccine And Therapeutics Market Forecast
10.4.3 UK mRNA Vaccine And Therapeutics Market Forecast
10.4.4 Italy mRNA Vaccine And Therapeutics Market Forecast
10.4.5 Russia mRNA Vaccine And Therapeutics Market Forecast
10.5 Middle East & Africa mRNA Vaccine And Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt mRNA Vaccine And Therapeutics Market Forecast
10.5.2 South Africa mRNA Vaccine And Therapeutics Market Forecast
10.5.3 Israel mRNA Vaccine And Therapeutics Market Forecast
10.5.4 Turkey mRNA Vaccine And Therapeutics Market Forecast
10.5.5 GCC Countries mRNA Vaccine And Therapeutics Market Forecast
10.6 Global mRNA Vaccine And Therapeutics Forecast by Type (2025-2030)
10.7 Global mRNA Vaccine And Therapeutics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Information
11.1.2 Argos Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Argos Therapeutics Main Business Overview
11.1.5 Argos Therapeutics Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech mRNA Vaccine And Therapeutics Product Offered
11.2.3 BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 CureVac
11.3.1 CureVac Company Information
11.3.2 CureVac mRNA Vaccine And Therapeutics Product Offered
11.3.3 CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 CureVac Main Business Overview
11.3.5 CureVac Latest Developments
11.4 eTheRNA
11.4.1 eTheRNA Company Information
11.4.2 eTheRNA mRNA Vaccine And Therapeutics Product Offered
11.4.3 eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 eTheRNA Main Business Overview
11.4.5 eTheRNA Latest Developments
11.5 Ethris
11.5.1 Ethris Company Information
11.5.2 Ethris mRNA Vaccine And Therapeutics Product Offered
11.5.3 Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Ethris Main Business Overview
11.5.5 Ethris Latest Developments
11.6 In-Cell-Art
11.6.1 In-Cell-Art Company Information
11.6.2 In-Cell-Art mRNA Vaccine And Therapeutics Product Offered
11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 In-Cell-Art Main Business Overview
11.6.5 In-Cell-Art Latest Developments
11.7 Moderna Therapeutics
11.7.1 Moderna Therapeutics Company Information
11.7.2 Moderna Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Moderna Therapeutics Main Business Overview
11.7.5 Moderna Therapeutics Latest Developments
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Information
11.8.2 Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Offered
11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sangamo Therapeutics Main Business Overview
11.8.5 Sangamo Therapeutics Latest Developments
11.9 Tiba Biotechnology
11.9.1 Tiba Biotechnology Company Information
11.9.2 Tiba Biotechnology mRNA Vaccine And Therapeutics Product Offered
11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Tiba Biotechnology Main Business Overview
11.9.5 Tiba Biotechnology Latest Developments
11.10 Translate Bio
11.10.1 Translate Bio Company Information
11.10.2 Translate Bio mRNA Vaccine And Therapeutics Product Offered
11.10.3 Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Translate Bio Main Business Overview
11.10.5 Translate Bio Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂